SKI Market

Indian Indices

Nifty

24,334.20 -1.75
(-0.01%)

Sensex

80,574.54 332.30
( 0.41%)

Bank Nifty

55,087.15 -304.10
( -0.55%)

Nifty IT

35,794.95 -125.45
( -0.35%)

Global Indices

Nasdaq

40,753.42 63.06
(0.15%)

Dow Jones

5,622.11 32.05
(0.57%)

Hang Seng

36,831.70 379.40
(1.04%)

Nikkei 225

8,496.80 1.95
(0.02%)

Forex

USD-INR

84.76 -0.40
(-0.47%)

EUR-INR

96.29 -0.73
(-0.75%)

GBP-INR

113.24 -0.94
(-0.82%)

JPY-INR

0.59 0.00
(-0.75%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

513.6236355

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

77.94

161568.16

EPS(TTM)

Face Value()

Div & Yield %

78.09

0.49

Back

Sudal Industries standalone net profit declines 99.48% in the September 2024 quarter

Nov 15,2024

Net profit of Sudal Industries declined 99.48% to Rs 0.66 crore in the quarter ended September 2024 as against Rs 126.51 crore during the previous quarter ended September 2023. Sales declined 8.58% to Rs 35.71 crore in the quarter ended September 2024 as against Rs 39.06 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	35.71	39.06	-9
OPM %	6.55	5.17	-
PBDT	1.67	1.54	8
PBT	1.18	1.10	7
NP	0.66	126.51	-99

24,334.20 -1.75 (-0.01%)

80,574.54 332.30 ( 0.41%)

55,087.15 -304.10 ( -0.55%)

35,794.95 -125.45 ( -0.35%)

40,753.42 63.06 (0.15%)

5,622.11 32.05 (0.57%)

36,831.70 379.40 (1.04%)

8,496.80 1.95 (0.02%)

84.76 -0.40 (-0.47%)

96.29 -0.73 (-0.75%)

113.24 -0.94 (-0.82%)

0.59 0.00 (-0.75%)